Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 22 Gynecologic 4 Genitourinary 4 Breast 4 Head & Neck 2 Tumor-Agnostic 1 Sarcoma 1 Other solid neoplasm 1 Gastrointestinal 1 CNS 1

Conditions

Interventions

trastuzumab deruxtecan 1 pembrolizumab 1 margetuximab 1 lenvatinib 1 larotrectinib 1 atezolizumab 1 Trastuzumab 1 Pemetrexed 1 Carboplatin 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Carboplatin × Tumor-Agnostic × Clear all

NCT02367781 2021-08-09

IMpower130

Hoffmann-La Roche

Phase 3 Completed

723 enrolled 28 charts 1 FDA

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡